IPOs: Weekly Review and Preview

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

IPO
Thinkstock
The initial public offering (IPO) market took a breather last week. Only one IPO was scheduled, and it did not occur. For next week, we are expecting two launches, one for a medical technology firm and the other an enterprise software company. Here’s a look.

We also published our list of the top 10 IPOs for 2014 last week.

Last week’s only scheduled IPO was Sundance Energy Australia, an onshore oil and gas E&P company operating in Texas, Oklahoma, Colorado and North Dakota. The Colorado-based company planned to raise $136 million by offering 7.75 million American Depositary Shares (ADS) at a price range of $16.50 to $18.50. At the midpoint of the proposed range, Sundance Energy Australia would command a fully diluted market value of $542 million. Each ADS is equal to 20 ordinary shares. The company is already traded on the Australian Stock Exchange under the ticker symbol ‘SEA’. The ADS will eventually trade on the Nasdaq under the ticker symbol ‘SNDE’. This one may launch next week — or not.

Lumenis Ltd. is an Israel-based maker of “minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications.” Products include specialized laser, intense pulsed light (IPL) devices, and RF technologies. The company will offer 6.25 million class B ordinary shares in an expected range of $15 to $17. Underwriters have a 30-day option on an additional 937,500 shares. Lumenis anticipates net proceeds of $90.2 million at the midpoint of the offering range, and the company says it will use the funds for operations and for other general corporate purposes. The company’s other class of shares are called simply “ordinary” shares and carry no additional voting or other privileges. The “ordinary” shares will automatically convert to class B shares when the the lock-up period ends, 181 days after the IPO. Lumenis stock will trade on the Nasdaq under the ticker symbol “LMNS”.

Varonis Systems Inc. is based in New York and has a substantial engineering presence in Israel. The company makes a software platform that helps enterprises make sense of their unstructured data. Varonis plans to offer 4.8 million shares of common stock in an expected price range of $17 to $19 a share. The underwriters have an option on an additional 720,000 shares. At the midpoint of the offering Varonis anticipates net proceeds of $77.9 million. The company said in its filing that it is using the IPO to raise capital and to create a public market for its common stock. Share will trade on the Nasdaq under the ticker symbol “VRNS”.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618